Although the U.S. Food and Drug Administration”s Vaccines and Related Biological Products Advisory Committee declared the effectiveness of FluMist, the new influenza vaccine developed by University Prof. Hunein “John” Maassab, the committee determined July 27 there is insufficient data to affirm its safety. For that reason the VRBPAC has decided to postpone a decision to […]
